Get all your news in one place.
100's of premium titles.
One app.
Start reading
AAP
AAP
National
Miklos Bolza

Cheaper diabetes drug halted by AstraZeneca court win

An Australian company has been restrained from listing drugs on the PBS competing with AstraZeneca. (Flavio Brancaleone/AAP PHOTOS)

Consumer hopes for a version of AstraZeneca's blockbuster diabetes drug Forxiga that doesn't hit hip pockets as hard have been dented by a court win to the pharma giant.

AstraZeneca sells a bottle of 28 tablets of Forxiga for $US25 ($A35) after federal government subsidies.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.